SCHEMBL6880360

SCHEMBL6880360

O=C(NO)C1=CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14880140 0.93 HDAC2 (1.00)
SCHEMBL5479808 0.91 HDAC2 (0.96)
SCHEMBL6965356 0.80
SCHEMBL6965359 0.80
SCHEMBL5515923 0.80
SCHEMBL29269499 0.77 HDAC2 (0.62)
SCHEMBL16850492 0.77 HDAC2 (0.62)
SCHEMBL2774579 0.75 HDAC2 (0.60)
SCHEMBL6965531 0.75
SCHEMBL5624438 0.75 HDAC2 (0.60)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025059442-A1 MODULATING PLANT RESPONSES TO STRESS AND GROWTH WITH CHEMICALS REMOTE EPIGENETICS INC. (US) 2025-03-20 WO claimed
CN-115192714-A Application of HDAC6 inhibitor in preparation of medicine for treating DNMT3A gene deletion cancer 沈阳药科大学 2022-10-18 CN claimed
EP-4029501-A1 COMBINATION OF POLYAROMATIC UREA DERIVATIVES AND GLUCOCORTICOID OR HDAC INHIBITOR FOR THE TREATMENT OF DISEASES OR CONDITIONS ASSOCIATED WITH MUSCLE CELLS AND/OR SATELLITE CELLS Anagenesis Biotechnologies (FR) 2022-07-20 EP claimed
US-20220184075-A1 PHARMACEUTICAL COMPOSITION CONTAINING HDAC6 INHIBITOR AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF ITCHING BNH RES CO LTD (KR) 2022-06-16 US claimed
US-20250122502-A1 Bifunctional Molecules and Methods of Using Thereof FLAGSHIP PIONEERING, INC. (US) 2025-04-17 US disclosed
WO-2025059442-A1 MODULATING PLANT RESPONSES TO STRESS AND GROWTH WITH CHEMICALS REMOTE EPIGENETICS INC. (US) 2025-03-20 WO disclosed
US-20250000847-A1 TREATMENT OF NEURODEGENERATIVE DISEASES WITH HDAC INHIBITORS CASE WESTERN RESERVE UNIVERSITY 2025-01-02 US disclosed
CN-115192714-B Use of HDAC6 inhibitors in the manufacture of a medicament for the treatment of DNMT3A gene-deficient cancers 沈阳药科大学 2024-09-17 CN disclosed
US-20230332145-A1 BIFUNCTIONAL MOLECULES AND METHODS OF USING THEREOF FLAGSHIP PIONEERING, INC. (US) 2023-10-19 US disclosed
WO-2023034440-A1 TREATMENT OF NEURODEGENERATIVE DISEASES WITH HDAC INHIBITORS CASE WESTERN RESERVE UNIVERSITY (US) 2023-03-09 WO disclosed
US-20230058189-A1 QUINOLIN-4-ONE AND 4(1H)-CINNOLINONE COMPOUNDS AND METHODS OF USING SAME Frequency Therapeutics, Inc. (US) 2023-02-23 US disclosed
US-20220339154-A1 COMPOSITIONS, SYSTEMS, AND METHODS FOR GENERATING INNER EAR HAIR CELLS FOR TREATMENT OF HEARING LOSS MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2022-10-27 US disclosed
US-9914717-B2 Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors THE BROAD INSTITUTE, INC. (US) 2018-03-13 US disclosed
US-9914717-B2 Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors THE BROAD INSTITUTE, INC. (US) 2018-03-13 US disclosed
US-20150368221-A1 CYCLOALKENYL HYDROXAMIC ACID DERIVATIVES AND THEIR USE AS HISTONE DEACETYLASE INHIBITORS THE BROAD INSTITUTE, INC. 2015-12-24 US disclosed
US-20150368221-A1 CYCLOALKENYL HYDROXAMIC ACID DERIVATIVES AND THEIR USE AS HISTONE DEACETYLASE INHIBITORS THE BROAD INSTITUTE, INC. 2015-12-24 US disclosed
US-20150368221-A1 CYCLOALKENYL HYDROXAMIC ACID DERIVATIVES AND THEIR USE AS HISTONE DEACETYLASE INHIBITORS THE BROAD INSTITUTE, INC. 2015-12-24 US disclosed
WO-2014100438-A1 CYCLOALKENYL HYDROXAMIC ACID DERIVATIVES AND THEIR USE AS HISTONE DEACETYLASE INHIBITORS THE BROAD INSTITUTE, INC. (US) 2014-06-26 WO disclosed
WO-2004043349-A2 ISOXAZOLINE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-ALPHA CONVERTING ENZYME BRISTOL-MYERS SQUIBB COMPANY (US) 2004-05-27 WO disclosed
WO-2003033556-A1 METHOD FOR PRODUCING SUBSTITUTED POLYMETHACRYLIMIDES FROM POLY-ALKYLMETHACRYLAMIDE-CO-ALKYLMETHACRYLATES, USING CYCLODEXTRINS Röhm GmbH & Co. KG (DE) 2003-04-24 WO disclosed